Events & Training for December 2018
Drug Discovery, Development and Lead Optimization
03 December 2018 - 05 December 2018
4th International Conference on Drug Discovery, Development and Lead Optimization (Drug Discovery-2018) organized by United Scientific Group, LLC (USG); will bring together multidisciplinary scientists and innovators from industry and academia from all over the world. The conference will be held in San Francisco, California from December 3-5, 2018 at DoubleTree by Hilton San Francisco International Airport Hotel.
DoubleTree by Hilton San Francisco International Airport Hotel
https://unitedscientificgroup.com/conferences/drug-discovery/symposia
4th Annual Oncolytic Virotherapy Summit
04 December 2018 - 06 December 2018
The 4th Oncolytic Virotherapy Summit is dedicated to improving the commercial success of oncolytic viruses, in stand-alone and combination therapies.
As many oncolytic viruses progress through the clinical pipelines, drug developers need to ensure that their therapies are safe, efficacious and commercially viable. Make sure you stay ahead of the game and join Oncolytic Virotherapy Summit, where you will have an opportunity to pick the brains of 100+ senior industry peers and tackle your challenges in discovery, clinical development, manufacturing and regulations of oncolytic virotherapy.
This year we will be incorporating commercial insights from companies such as Amgen, Pfizer, Merck, Replimune, Targovax, DNAtrix, Vyriad, Virogin and many more, which will allow you to learn from their case studies and improve your development strategies. Participate in the interactive roundtable and workshops to build strategies that maximise success in the clinic and commercially. Want to know more?
Hilton Boston Back Bay Hotel Boston MA, USA
http://oncolyticvirotherapies.com/?utm_source=MediaPartner&utm_medium=DrugDiscoveryToday&utm_campaign=9566-OV-DrugDiscoveryToday
ACI's 7th Lung Cancer Screening & Continuum of Care
12 December 2018 - 13 December 2018
This two-day event will focus on implementing lung screening programs and services to maximize competitive advantage, meet increased demand and exceed patient satisfaction. The goal of this event is to bring industry leaders together, highlight the best practice achievements, and discuss the current issues and developments in imaging services for the thoracic oncology community.
Lung cancer is the leading cause of cancer-related deaths in the United States. This largely stems from lung cancer’s minimal symptoms in its early stages, which is when the disease is most treatable. For this reason, there is a push for regions to offer screening services for their populations, enabling potential patients to receive care at the most opportune time. Providing this service to potential patients comes with its own challenges, such as motivating patients to get screened regularly, generating funding for these services, raising awareness in your community and many more.
Tampa, Florida, USA
https://www.wplgroup.com/aci/event/7th-lung-cancer-screening-continuum-care/